314 related articles for article (PubMed ID: 26970828)
1. Silver nanoparticles strongly enhance and restore bactericidal activity of inactive antibiotics against multiresistant Enterobacteriaceae.
Panáček A; Smékalová M; Večeřová R; Bogdanová K; Röderová M; Kolář M; Kilianová M; Hradilová Š; Froning JP; Havrdová M; Prucek R; Zbořil R; Kvítek L
Colloids Surf B Biointerfaces; 2016 Jun; 142():392-399. PubMed ID: 26970828
[TBL] [Abstract][Full Text] [Related]
2. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
[TBL] [Abstract][Full Text] [Related]
3. Cerium oxide nanoparticles as potential antibiotic adjuvant. Effects of CeO
Bellio P; Luzi C; Mancini A; Cracchiolo S; Passacantando M; Di Pietro L; Perilli M; Amicosante G; Santucci S; Celenza G
Biochim Biophys Acta Biomembr; 2018 Nov; 1860(11):2428-2435. PubMed ID: 30026034
[TBL] [Abstract][Full Text] [Related]
4. Mature Pseudomonas aeruginosa biofilms prevail compared to young biofilms in the presence of ceftazidime.
Bowler LL; Zhanel GG; Ball TB; Saward LL
Antimicrob Agents Chemother; 2012 Sep; 56(9):4976-9. PubMed ID: 22777043
[TBL] [Abstract][Full Text] [Related]
5. Time-kill synergy tests of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
Yim H; Woo H; Song W; Park MJ; Kim HS; Lee KM; Hur J; Park MS
Ann Clin Lab Sci; 2011; 41(1):39-43. PubMed ID: 21325253
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of the antibacterial potential of ZnO nanoparticles against extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated from a tertiary care hospital of North India.
Ansari MA; Khan HM; Khan AA; Sultan A; Azam A
Appl Microbiol Biotechnol; 2012 Apr; 94(2):467-77. PubMed ID: 22159886
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of ceftazidime-avibactam and comparator agents when tested against bacterial isolates causing infection in cancer patients (2013-2014).
Sader HS; Castanheira M; Jones RN; Flamm RK
Diagn Microbiol Infect Dis; 2017 Mar; 87(3):261-265. PubMed ID: 28069328
[TBL] [Abstract][Full Text] [Related]
8. Biologically synthesized copper oxide nanoparticles enhanced intracellular damage in ciprofloxacin resistant ESBL producing bacteria.
Rajivgandhi G; Maruthupandy M; Muneeswaran T; Ramachandran G; Manoharan N; Quero F; Anand M; Song JM
Microb Pathog; 2019 Feb; 127():267-276. PubMed ID: 30550842
[TBL] [Abstract][Full Text] [Related]
9. The use of eugenol in combination with cefotaxime and ciprofloxacin to combat ESBL-producing quinolone-resistant pathogenic Enterobacteriaceae.
Dhara L; Tripathi A
J Appl Microbiol; 2020 Dec; 129(6):1566-1576. PubMed ID: 32502298
[TBL] [Abstract][Full Text] [Related]
10. Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Yagi T; Wachino J; Kurokawa H; Suzuki S; Yamane K; Doi Y; Shibata N; Kato H; Shibayama K; Arakawa Y
J Clin Microbiol; 2005 Jun; 43(6):2551-8. PubMed ID: 15956362
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
[TBL] [Abstract][Full Text] [Related]
13. Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae.
Ríos E; López MC; Rodríguez-Avial I; Culebras E; Picazo JJ
J Med Microbiol; 2017 Feb; 66(2):169-174. PubMed ID: 27902381
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.
Soren O; Brinch KS; Patel D; Liu Y; Liu A; Coates A; Hu Y
Antimicrob Agents Chemother; 2015 Oct; 59(10):6233-40. PubMed ID: 26248380
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial action of zinc oxide nanoparticles in combination with ciprofloxacin and ceftazidime against multidrug-resistant Acinetobacter baumannii.
Ghasemi F; Jalal R
J Glob Antimicrob Resist; 2016 Sep; 6():118-122. PubMed ID: 27530853
[TBL] [Abstract][Full Text] [Related]
16. [Bactericidal effect of cefotaxime-sulbactam and imipenem combined with gentamicin and/or ciprofloxacin against CTX-1 producing Klebsiella pneumoniae].
Archambaud M; Labau E; Clave D; Suc C
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):534-9. PubMed ID: 2677925
[TBL] [Abstract][Full Text] [Related]
17. [Genotype of extended-spectrum beta-lactamases produced by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in surgical intensive care unit].
Wang PY; Liu YC; Zhao M; Sun LY; Luo W; Gao HQ; Wan YL
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 36(6):637-41. PubMed ID: 15605100
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Enterobacteriaceae isolates obtained from a tertiary care hospital in Mexico, which produces extended-spectrum β-lactamase.
Morfín-Otero R; Mendoza-Olazarán S; Silva-Sánchez J; Rodríguez-Noriega E; Laca-Díaz J; Tinoco-Carrillo P; Petersen L; López P; Reyna-Flores F; Alcantar-Curiel D; Garza-Ramos U; Garza-González E
Microb Drug Resist; 2013 Oct; 19(5):378-83. PubMed ID: 23725513
[TBL] [Abstract][Full Text] [Related]
19. Assessment of antibiotic resistance in Klebsiella pneumoniae exposed to sequential in vitro antibiotic treatments.
Kim J; Jo A; Chukeatirote E; Ahn J
Ann Clin Microbiol Antimicrob; 2016 Dec; 15(1):60. PubMed ID: 27938381
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of efficiency of screening extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent.
Lee K; Lim JK; Yong D; Yum J; Chong Y; Okamoto R; Inoue M
J Clin Microbiol; 2001 Oct; 39(10):3696-9. PubMed ID: 11574594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
